期刊文献+

丙丁酚的药理作用及临床应用研究新进展 被引量:3

Recent progress in the studies of pharmacological characteristics and clinical therapeutic application on probucol
下载PDF
导出
摘要 丙丁酚具有调血脂、抗氧化、抗炎、改善内皮细胞功能、抑制血管内膜增生等作用,在防治心血管疾病和糖尿病等方面有广阔的应用前景。笔者对其药理研究及临床应用进行综述。 Probucol not only has an effect on modulating lipids, but also plays roles in antioxidation, antinflammatoin, improving the function of vascular endothelial cells and inhibiting neoinitial hyperplasia, which can support various therapeutic application in cardiaovascular diseases, diabetes and other diseases.
作者 王哲 杨向红
出处 《实用药物与临床》 CAS 2007年第1期46-48,共3页 Practical Pharmacy and Clinical Remedies
关键词 丙丁酚 抗氧化 心血管病 糖尿病 Probucol Antioxidation Cardiovascular diseases Diabetes
  • 相关文献

参考文献24

  • 1Kuzyya M, Kuzuya F. Probucol as an antioxidant and antiatherogenic drug[J]. Free Radic Biol. Med, 1993,14(1) :67-77.
  • 2Michihara A, Sawamura M, Yamori Y, et al. Probucol decreases mevalonate pyrophosphate decarboxylase in the rat liver[ J]. Biol Pharm Bull, 2003, 26(10) : 1484-1486.
  • 3Elda F, Ilaria Z, Francesca Z, et al. Probucol Inhibits ABCA1-Mediated Celular Lipid Efflux [ J ]. Arterioscler Thromb Vase Biol, 2004, 24(12) : 2345-2350.
  • 4Duong M, Collins HL, Jin W. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages[J ]. Arterioseler Thromb Vasc Biol, 2006, 26(3) :541-547.
  • 5Kenichi H, Chiaki I, Kenichi T, et al. Probueol Enhances the Expression of Human Hepatic Scavenger Receptor Class B Type I, Possibly Through a Species-Specific Mechanism[J].Arterioscler Thromb Vase Biol, 2005, 25(11) :2422-2427.
  • 6Iqbal M, Sharma SD, Okada S. Probucol as a potent inhibitor of oxygen radical-induced lipid peroxidation and DNA damage: in vitro studies[J]. Redox Rep, 2004, 9(3) : 167-172.
  • 7Hong SC, Zhao SP, Wu ZH. Probucol up-regulates paraoxonase 1 expression in hepatocytes of hypercholesterolemic rabbits[J].J Cardiovasc Pharmacol, 2006, 47(1):77-81.
  • 8Niemann-Jonsson A, Dimayuga P, Jovinge S. Accumulation of LDL in rat arteries is associated with activation of tumor necrosis factor-αexpression [ J ]. Arterioscler Thromb Vasc Biol,2000, 20( 10 ) : 2205-2211.
  • 9Ryo N, Kensuke E, Youji M. Probucol Attenuates Left Ventricular Dysfunction and Remodeling in Tachycardia-Induced Heart Failure[J].Circulation, 2002,106(3 ) : 362-367.
  • 10Choy K, Beck K, Png FY, et al. Processes involved in the sitespecific effect of probucol on atherosclerosis in aplipoprotein E gene knockout mice[J]. Arterioscler Thromb Vase Biol, 2005,25(8) : 1684-1690.

同被引文献30

  • 1陈宝玲,张正,郑英丽,顾德良,方丽.普罗布考的HPLC分析及其在Beagle犬体内的药动学初探[J].中国药学杂志,2004,39(9):691-693. 被引量:4
  • 2程晓静,王绿娅,刘晓惠.丙丁酚防治动脉粥样硬化的研究新进展[J].中国动脉硬化杂志,2004,12(5):611-614. 被引量:9
  • 3刘广平,王艳秋,张海燕,张雪晶.再生麻纤维抗菌性研究[J].河北工业科技,2006,23(2):70-72. 被引量:7
  • 4周永凯,张建春,张华.大麻纤维的抗菌性及抗菌机制[J].纺织学报,2007,28(6):12-15. 被引量:56
  • 5Buckley MM, Goa KL, Price AH, et al. Probucol. a reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia[J]. Drugs, 1989, 37(6): 761-800.
  • 6Jeon H, Lee S, Kim TE, et al. Pharmacokinetics and tolerability of probucol after multiple oral administrations in healthy volunteers[J]. Int J Clin Pharmacol Ther, 2011, 49(11): 688-695.
  • 7Kim KP, Kim BH, Lim KS, et al. Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteers[J]. Clin Ther, 2009, 31(10): 2098-2106.
  • 8Jiko M, Yano I, Wakasugi H, et al. Evaluation of pharmacokinetic interaction between cyclosporin A and probucol in rats[J]. Pharm Res, 2002, 19(9): 1362-1367.
  • 9Reinoehl J, Frankovich D, Machado C, et al. Probucol-associated tachyarrhythmic events and QT prolongation: importance of gender[J]. Am Heart J, 1996, 131(6): 1184-1191.
  • 10Merat S, Malekzadeh R, Sohrabi MR, et al. Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study[J]. J Hepatol, 2003, 38(4): 414-418.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部